22 April 2021

CEO of RocketVax, Dr. Vladimir Cmiljanovic, spoke to Watson about the development of a next-generation SARS-CoV-2 vaccine, RVX-13

“There is light at the end of the tunnel. Progress is being made in vaccines against SARS-CoV-2, if somewhat slowly, particularly in Switzerland.